-
1
-
-
60149110364
-
USRDS 2013 Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States
-
National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
-
USRDS 2013 Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States. U.S. Renal Data System 2013, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
-
(2013)
U.S. Renal Data System
-
-
-
2
-
-
79959929236
-
Counselling the elderly between hope and reality
-
De Fijter J.W. Counselling the elderly between hope and reality. Nephrol Dial Transplant 2011, 26:2079-2081.
-
(2011)
Nephrol Dial Transplant
, vol.26
, pp. 2079-2081
-
-
De Fijter, J.W.1
-
3
-
-
80053333600
-
Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes
-
Tonelli M., Wiebe N., Knoll G., et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant 2011, 11:2093-2109.
-
(2011)
Am J Transplant
, vol.11
, pp. 2093-2109
-
-
Tonelli, M.1
Wiebe, N.2
Knoll, G.3
-
5
-
-
84960397450
-
ANZOD Registry Report 2013
-
ANZDATA Registry and ANZOD Registry, Adelaide
-
Excell L.M.V., Russ G. ANZOD Registry Report 2013. ANZOD Registry Report 2013, ANZDATA Registry and ANZOD Registry, Adelaide.
-
(2013)
ANZOD Registry Report
-
-
Excell, L.M.V.1
Russ, G.2
-
7
-
-
78650262647
-
Intermediate-term outcomes associated with kidney transplantation in recipients 80 years and older: an analysis of the OPTN/UNOS database
-
Huang E., Poommipanit N., Sampaio M.S., et al. Intermediate-term outcomes associated with kidney transplantation in recipients 80 years and older: an analysis of the OPTN/UNOS database. Transplantation 2010, 90:974-979.
-
(2010)
Transplantation
, vol.90
, pp. 974-979
-
-
Huang, E.1
Poommipanit, N.2
Sampaio, M.S.3
-
8
-
-
67649644196
-
Evaluating options for utility-based kidney allocation
-
Segev D.L. Evaluating options for utility-based kidney allocation. Am J Transplant 2009, 9:1513-1518.
-
(2009)
Am J Transplant
, vol.9
, pp. 1513-1518
-
-
Segev, D.L.1
-
9
-
-
59249098683
-
An old virtue to improve senior programs
-
De Fijter J.W. An old virtue to improve senior programs. Transpl Int 2009, 22:259-268.
-
(2009)
Transpl Int
, vol.22
, pp. 259-268
-
-
De Fijter, J.W.1
-
10
-
-
57749173132
-
The effects of polypharmacy in older adults
-
Hilmer S.N., Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther 2009, 85:86-88.
-
(2009)
Clin Pharmacol Ther
, vol.85
, pp. 86-88
-
-
Hilmer, S.N.1
Gnjidic, D.2
-
11
-
-
12744278083
-
Age and immune response in organ transplantation
-
Martins P.N., Pratschke J., Pascher A., et al. Age and immune response in organ transplantation. Transplantation 2005, 79:127-132.
-
(2005)
Transplantation
, vol.79
, pp. 127-132
-
-
Martins, P.N.1
Pratschke, J.2
Pascher, A.3
-
12
-
-
77955664688
-
Aging of the innate immune system
-
Shaw A.C., Joshi S., Greenwood H., Panda A., Lord J.M. Aging of the innate immune system. Curr Opin Immunol 2010, 22:507-513.
-
(2010)
Curr Opin Immunol
, vol.22
, pp. 507-513
-
-
Shaw, A.C.1
Joshi, S.2
Greenwood, H.3
Panda, A.4
Lord, J.M.5
-
13
-
-
84867097855
-
Solid-organ transplantation in older adults: current status and future research
-
Abecassis M., Bridges N.D., Clancy C.J., et al. Solid-organ transplantation in older adults: current status and future research. Am J Transplant 2012, 12:2608-2622.
-
(2012)
Am J Transplant
, vol.12
, pp. 2608-2622
-
-
Abecassis, M.1
Bridges, N.D.2
Clancy, C.J.3
-
14
-
-
21044451726
-
The influence of age on T cell generation and TCR diversity
-
Naylor K., Li G., Vallejo A.N., et al. The influence of age on T cell generation and TCR diversity. J Immunol 2005, 174:7446-7452.
-
(2005)
J Immunol
, vol.174
, pp. 7446-7452
-
-
Naylor, K.1
Li, G.2
Vallejo, A.N.3
-
15
-
-
40849145398
-
T cell subset-specific susceptibility to aging
-
Czesnikiewicz-Guzik M., Lee W.W., Cui D., et al. T cell subset-specific susceptibility to aging. Clin Immunol 2008, 127:107-118.
-
(2008)
Clin Immunol
, vol.127
, pp. 107-118
-
-
Czesnikiewicz-Guzik, M.1
Lee, W.W.2
Cui, D.3
-
16
-
-
84855961969
-
Advances in direct T-cell alloreactivity: function, avidity, biophysics and structure
-
Smith C., Miles J.J., Khanna R. Advances in direct T-cell alloreactivity: function, avidity, biophysics and structure. Am J Transplant 2012, 12:15-26.
-
(2012)
Am J Transplant
, vol.12
, pp. 15-26
-
-
Smith, C.1
Miles, J.J.2
Khanna, R.3
-
17
-
-
77949495502
-
Prolonged graft survival in older recipient mice is determined by impaired effector T-cell but intact regulatory T-cell responses
-
Denecke C., Bedi D.S., Ge X., et al. Prolonged graft survival in older recipient mice is determined by impaired effector T-cell but intact regulatory T-cell responses. PLoS One 2010, 5:e9232.
-
(2010)
PLoS One
, vol.5
, pp. e9232
-
-
Denecke, C.1
Bedi, D.S.2
Ge, X.3
-
18
-
-
78650899002
-
Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression
-
Lo D.J., Weaver T.A., Stempora L., et al. Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression. Am J Transplant 2011, 11:22-33.
-
(2011)
Am J Transplant
, vol.11
, pp. 22-33
-
-
Lo, D.J.1
Weaver, T.A.2
Stempora, L.3
-
19
-
-
0034653643
-
Increased immunosuppressive vulnerability in elderly renal transplant recipients
-
Meier-Kriesche H.U., Ojo A., Hanson J., et al. Increased immunosuppressive vulnerability in elderly renal transplant recipients. Transplantation 2000, 69:885-889.
-
(2000)
Transplantation
, vol.69
, pp. 885-889
-
-
Meier-Kriesche, H.U.1
Ojo, A.2
Hanson, J.3
-
20
-
-
58249108425
-
The OPTN/UNOS renal transplant registry
-
Cecka J.M. The OPTN/UNOS renal transplant registry. Clin Transpl 2004, 1-16.
-
(2004)
Clin Transpl
, pp. 1-16
-
-
Cecka, J.M.1
-
21
-
-
12444346875
-
Renal transplant recipients over aged 60 have diminished immune activity and a low risk of rejection
-
Friedman A.L., Goker O., Kalish M.A., et al. Renal transplant recipients over aged 60 have diminished immune activity and a low risk of rejection. Int Urol Nephrol 2004, 36:451-456.
-
(2004)
Int Urol Nephrol
, vol.36
, pp. 451-456
-
-
Friedman, A.L.1
Goker, O.2
Kalish, M.A.3
-
22
-
-
35848932107
-
Renal transplantation outcomes: a comparative analysis between elderly and younger recipients
-
Mendonca H.M., Dos Reis M.A., De Castro De Cintra Sesso R., Camara N.O., Pacheco-Silva A. Renal transplantation outcomes: a comparative analysis between elderly and younger recipients. Clin Transplant 2007, 21:755-760.
-
(2007)
Clin Transplant
, vol.21
, pp. 755-760
-
-
Mendonca, H.M.1
Dos Reis, M.A.2
De Castro De Cintra Sesso, R.3
Camara, N.O.4
Pacheco-Silva, A.5
-
23
-
-
79953798838
-
Kidney allocation and the aging immune response
-
Tullius S.G., Milford E. Kidney allocation and the aging immune response. N Engl J Med 2011, 364:1369-1370.
-
(2011)
N Engl J Med
, vol.364
, pp. 1369-1370
-
-
Tullius, S.G.1
Milford, E.2
-
24
-
-
0030815344
-
Significance of the donor age effect on kidney transplants
-
Terasaki P.I., Gjertson D.W., Cecka J.M., Takemoto S., Cho Y.W. Significance of the donor age effect on kidney transplants. Clin Transplant 1997, 11:366-372.
-
(1997)
Clin Transplant
, vol.11
, pp. 366-372
-
-
Terasaki, P.I.1
Gjertson, D.W.2
Cecka, J.M.3
Takemoto, S.4
Cho, Y.W.5
-
25
-
-
22344433724
-
The impact of age on rejection in kidney transplantation
-
De Fijter J.W. The impact of age on rejection in kidney transplantation. Drugs Aging 2005, 22:433-449.
-
(2005)
Drugs Aging
, vol.22
, pp. 433-449
-
-
De Fijter, J.W.1
-
26
-
-
0034923878
-
Increased immunogenicity and cause of graft loss of old donor kidneys
-
De Fijter J.W., Mallat M.J., Doxiadis Ii, et al. Increased immunogenicity and cause of graft loss of old donor kidneys. J Am Soc Nephrol 2001, 12:1538-1546.
-
(2001)
J Am Soc Nephrol
, vol.12
, pp. 1538-1546
-
-
De Fijter, J.W.1
Mallat, M.J.2
Doxiadis, I.3
-
27
-
-
84860473178
-
Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant
-
Wiebe C., Gibson I.W., Blydt-Hansen T.D., et al. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant 2012, 12:1157-1167.
-
(2012)
Am J Transplant
, vol.12
, pp. 1157-1167
-
-
Wiebe, C.1
Gibson, I.W.2
Blydt-Hansen, T.D.3
-
28
-
-
0035679073
-
Interaction between acute rejection and recipient age on long-term renal allograft survival
-
Meier-Kriesche H.U., Srinivas T.R., Kaplan B. Interaction between acute rejection and recipient age on long-term renal allograft survival. Transplant Proc 2001, 33:3425-3426.
-
(2001)
Transplant Proc
, vol.33
, pp. 3425-3426
-
-
Meier-Kriesche, H.U.1
Srinivas, T.R.2
Kaplan, B.3
-
29
-
-
0343628707
-
Relationship of recipient age and development of chronic allograft failure
-
Meier-Kriesche H.U., Ojo A.O., Cibrik D.M., et al. Relationship of recipient age and development of chronic allograft failure. Transplantation 2000, 70:306-310.
-
(2000)
Transplantation
, vol.70
, pp. 306-310
-
-
Meier-Kriesche, H.U.1
Ojo, A.O.2
Cibrik, D.M.3
-
30
-
-
84876297635
-
Kidney transplantation in the older adult
-
Knoll G.A. Kidney transplantation in the older adult. Am J Kidney Dis 2013, 61:790-797.
-
(2013)
Am J Kidney Dis
, vol.61
, pp. 790-797
-
-
Knoll, G.A.1
-
31
-
-
34547876470
-
Immunosuppression of the elderly kidney transplant recipient
-
Danovitch G.M., Gill J., Bunnapradist S. Immunosuppression of the elderly kidney transplant recipient. Transplantation 2007, 84:285-291.
-
(2007)
Transplantation
, vol.84
, pp. 285-291
-
-
Danovitch, G.M.1
Gill, J.2
Bunnapradist, S.3
-
32
-
-
0035070003
-
Exponentially increased risk of infectious death in older renal transplant recipients
-
Meier-Kriesche H.U., Ojo A.O., Hanson J.A., Kaplan B. Exponentially increased risk of infectious death in older renal transplant recipients. Kidney Int 2001, 59:1539-1543.
-
(2001)
Kidney Int
, vol.59
, pp. 1539-1543
-
-
Meier-Kriesche, H.U.1
Ojo, A.O.2
Hanson, J.A.3
Kaplan, B.4
-
33
-
-
27644454209
-
Influence of age in renal transplant infections: cases and controls study
-
Trouillhet I., Benito N., Cervera C., et al. Influence of age in renal transplant infections: cases and controls study. Transplantation 2005, 80:989-992.
-
(2005)
Transplantation
, vol.80
, pp. 989-992
-
-
Trouillhet, I.1
Benito, N.2
Cervera, C.3
-
34
-
-
79953812140
-
Renal transplantation in the elderly: South Indian experience
-
Mohamed Ali A.A., Abraham G., Khanna P., et al. Renal transplantation in the elderly: South Indian experience. Int Urol Nephrol 2011, 43:265-271.
-
(2011)
Int Urol Nephrol
, vol.43
, pp. 265-271
-
-
Mohamed Ali, A.A.1
Abraham, G.2
Khanna, P.3
-
35
-
-
55749114725
-
What is the best immunosuppression for the elderly kidney transplantation patient?
-
Ladriere M. What is the best immunosuppression for the elderly kidney transplantation patient?. Nephrol Ther 2008, 4:S179-S183.
-
(2008)
Nephrol Ther
, vol.4
, pp. S179-S183
-
-
Ladriere, M.1
-
36
-
-
84879514567
-
Managing transplant rejection in the elderly: the benefits of less aggressive immunosuppressive regimens
-
Heldal K., Midtvedt K. Managing transplant rejection in the elderly: the benefits of less aggressive immunosuppressive regimens. Drugs Aging 2013, 30:459-466.
-
(2013)
Drugs Aging
, vol.30
, pp. 459-466
-
-
Heldal, K.1
Midtvedt, K.2
-
37
-
-
9644299890
-
Drug therapy in the elderly
-
Turnheim K. Drug therapy in the elderly. Exp Gerontol 2004, 39:1731-1738.
-
(2004)
Exp Gerontol
, vol.39
, pp. 1731-1738
-
-
Turnheim, K.1
-
38
-
-
39149117687
-
The clinical implications of ageing for rational drug therapy
-
Shi S., Morike K., Klotz U. The clinical implications of ageing for rational drug therapy. Eur J Clin Pharmacol 2008, 64:183-199.
-
(2008)
Eur J Clin Pharmacol
, vol.64
, pp. 183-199
-
-
Shi, S.1
Morike, K.2
Klotz, U.3
-
39
-
-
0347319044
-
Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications
-
Mangoni A.A., Jackson S.H. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2004, 57:6-14.
-
(2004)
Br J Clin Pharmacol
, vol.57
, pp. 6-14
-
-
Mangoni, A.A.1
Jackson, S.H.2
-
40
-
-
0035214978
-
Immunosuppression in elderly renal transplant recipients: are current regimens too aggressive?
-
Meier-Kriesche H.U., Kaplan B. Immunosuppression in elderly renal transplant recipients: are current regimens too aggressive?. Drugs Aging 2001, 18:751-759.
-
(2001)
Drugs Aging
, vol.18
, pp. 751-759
-
-
Meier-Kriesche, H.U.1
Kaplan, B.2
-
41
-
-
1942435960
-
Drug therapy in transplant recipients: special considerations in the elderly with comorbid conditions
-
Bernardo J.F., Mccauley J. Drug therapy in transplant recipients: special considerations in the elderly with comorbid conditions. Drugs Aging 2004, 21:323-348.
-
(2004)
Drugs Aging
, vol.21
, pp. 323-348
-
-
Bernardo, J.F.1
Mccauley, J.2
-
42
-
-
14044276929
-
Do men and women differ in proximal small intestinal CYP3A or P-glycoprotein expression?
-
Paine M.F., Ludington S.S., Chen M.L., Stewart P.W., Huang S.M., Watkins P.B. Do men and women differ in proximal small intestinal CYP3A or P-glycoprotein expression?. Drug Metab Dispos 2005, 33:426-433.
-
(2005)
Drug Metab Dispos
, vol.33
, pp. 426-433
-
-
Paine, M.F.1
Ludington, S.S.2
Chen, M.L.3
Stewart, P.W.4
Huang, S.M.5
Watkins, P.B.6
-
43
-
-
12644272784
-
Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine
-
Lown K.S., Mayo R.R., Leichtman A.B., et al. Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin Pharmacol Ther 1997, 62:248-260.
-
(1997)
Clin Pharmacol Ther
, vol.62
, pp. 248-260
-
-
Lown, K.S.1
Mayo, R.R.2
Leichtman, A.B.3
-
44
-
-
34548695887
-
Expression of CYP3A isoforms and P-glycoprotein in human stomach, jejunum and ileum
-
Canaparo R., Finnstrom N., Serpe L., et al. Expression of CYP3A isoforms and P-glycoprotein in human stomach, jejunum and ileum. Clin Exp Pharmacol Physiol 2007, 34:1138-1144.
-
(2007)
Clin Exp Pharmacol Physiol
, vol.34
, pp. 1138-1144
-
-
Canaparo, R.1
Finnstrom, N.2
Serpe, L.3
-
45
-
-
31344466713
-
Effect of intestinal CYP3A5 on postoperative tacrolimus trough levels in living-donor liver transplant recipients
-
Uesugi M., Masuda S., Katsura T., Oike F., Takada Y., Inui K. Effect of intestinal CYP3A5 on postoperative tacrolimus trough levels in living-donor liver transplant recipients. Pharmacogenet Genomics 2006, 16:119-127.
-
(2006)
Pharmacogenet Genomics
, vol.16
, pp. 119-127
-
-
Uesugi, M.1
Masuda, S.2
Katsura, T.3
Oike, F.4
Takada, Y.5
Inui, K.6
-
46
-
-
42149176588
-
Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients
-
Fukudo M., Yano I., Yoshimura A., et al. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients. Pharmacogenet Genomics 2008, 18:413-423.
-
(2008)
Pharmacogenet Genomics
, vol.18
, pp. 413-423
-
-
Fukudo, M.1
Yano, I.2
Yoshimura, A.3
-
47
-
-
0036231685
-
The aging liver: structural and functional changes and their consequences for drug treatment in old age
-
Zeeh J., Platt D. The aging liver: structural and functional changes and their consequences for drug treatment in old age. Gerontology 2002, 48:121-127.
-
(2002)
Gerontology
, vol.48
, pp. 121-127
-
-
Zeeh, J.1
Platt, D.2
-
48
-
-
11944274532
-
The influence of age and sex on the clearance of cytochrome P450 3A substrates
-
Cotreau M.M., Von Moltke L.L., Greenblatt D.J. The influence of age and sex on the clearance of cytochrome P450 3A substrates. Clin Pharmacokinet 2005, 44:33-60.
-
(2005)
Clin Pharmacokinet
, vol.44
, pp. 33-60
-
-
Cotreau, M.M.1
Von Moltke, L.L.2
Greenblatt, D.J.3
-
49
-
-
25844458497
-
Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in elderly individuals
-
Ginsberg G., Hattis D., Russ A., Sonawane B. Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in elderly individuals. Environ Health Perspect 2005, 113:1243-1249.
-
(2005)
Environ Health Perspect
, vol.113
, pp. 1243-1249
-
-
Ginsberg, G.1
Hattis, D.2
Russ, A.3
Sonawane, B.4
-
50
-
-
33646165075
-
Erythromycin breath test results in elderly, very elderly, and frail elderly persons
-
Schwartz J.B. Erythromycin breath test results in elderly, very elderly, and frail elderly persons. Clin Pharmacol Ther 2006, 79:440-448.
-
(2006)
Clin Pharmacol Ther
, vol.79
, pp. 440-448
-
-
Schwartz, J.B.1
-
51
-
-
0042707810
-
When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly
-
Turnheim K. When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol 2003, 38:843-853.
-
(2003)
Exp Gerontol
, vol.38
, pp. 843-853
-
-
Turnheim, K.1
-
52
-
-
46049118014
-
Age, model for end-stage liver disease score, and organ functioning predict posttransplant tacrolimus neurotoxicity
-
Dimartini A., Fontes P., Dew M.A., Lotrich F.E., De Vera M. Age, model for end-stage liver disease score, and organ functioning predict posttransplant tacrolimus neurotoxicity. Liver Transpl 2008, 14:815-822.
-
(2008)
Liver Transpl
, vol.14
, pp. 815-822
-
-
Dimartini, A.1
Fontes, P.2
Dew, M.A.3
Lotrich, F.E.4
De Vera, M.5
-
53
-
-
50849133886
-
The aging kidney
-
Zhou X.J., Rakheja D., Yu X., Saxena R., Vaziri N.D., Silva F.G. The aging kidney. Kidney Int 2008, 74:710-720.
-
(2008)
Kidney Int
, vol.74
, pp. 710-720
-
-
Zhou, X.J.1
Rakheja, D.2
Yu, X.3
Saxena, R.4
Vaziri, N.D.5
Silva, F.G.6
-
54
-
-
24644438250
-
Age-related changes in liver structure and function: implications for disease?
-
Schmucker D.L. Age-related changes in liver structure and function: implications for disease?. Exp Gerontol 2005, 40:650-659.
-
(2005)
Exp Gerontol
, vol.40
, pp. 650-659
-
-
Schmucker, D.L.1
-
55
-
-
69949163535
-
Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions
-
Kuypers D.R. Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions. Drugs Aging 2009, 26:715-737.
-
(2009)
Drugs Aging
, vol.26
, pp. 715-737
-
-
Kuypers, D.R.1
-
56
-
-
55549129627
-
Pharmacodynamic parameters of immunosuppressive drugs are not correlated with age, duration of dialysis, percentage of lymphocytes or lymphocyte stimulation index in renal transplant recipients
-
Sugiyama K., Isogai K., Toyama A., et al. Pharmacodynamic parameters of immunosuppressive drugs are not correlated with age, duration of dialysis, percentage of lymphocytes or lymphocyte stimulation index in renal transplant recipients. Biol Pharm Bull 2008, 31:2146-2149.
-
(2008)
Biol Pharm Bull
, vol.31
, pp. 2146-2149
-
-
Sugiyama, K.1
Isogai, K.2
Toyama, A.3
-
57
-
-
0031727173
-
Drug dosage in the elderly. Is it rational?
-
Turnheim K. Drug dosage in the elderly. Is it rational?. Drugs Aging 1998, 13:357-379.
-
(1998)
Drugs Aging
, vol.13
, pp. 357-379
-
-
Turnheim, K.1
-
58
-
-
24044443235
-
Pharmacokinetic considerations relating to tacrolimus dosing in the elderly
-
Staatz C.E., Tett S.E. Pharmacokinetic considerations relating to tacrolimus dosing in the elderly. Drugs Aging 2005, 22:541-557.
-
(2005)
Drugs Aging
, vol.22
, pp. 541-557
-
-
Staatz, C.E.1
Tett, S.E.2
-
59
-
-
84893233177
-
The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation
-
Hesselink D.A., Bouamar R., Elens L., Van Schaik R.H., Van Gelder T. The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation. Clin Pharmacokinet 2014, 53:123-139.
-
(2014)
Clin Pharmacokinet
, vol.53
, pp. 123-139
-
-
Hesselink, D.A.1
Bouamar, R.2
Elens, L.3
Van Schaik, R.H.4
Van Gelder, T.5
-
60
-
-
34447549311
-
Tacrolimus pharmacokinetics and pharmacogenetics: influence of adenosine triphosphate-binding cassette B1 (ABCB1) and cytochrome (CYP) 3A polymorphisms
-
Op Den Buijsch R.A., Christiaans M.H., Stolk L.M., et al. Tacrolimus pharmacokinetics and pharmacogenetics: influence of adenosine triphosphate-binding cassette B1 (ABCB1) and cytochrome (CYP) 3A polymorphisms. Fundam Clin Pharmacol 2007, 21:427-435.
-
(2007)
Fundam Clin Pharmacol
, vol.21
, pp. 427-435
-
-
Op Den Buijsch, R.A.1
Christiaans, M.H.2
Stolk, L.M.3
-
61
-
-
3242772986
-
Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation
-
Staatz C.E., Tett S.E. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet 2004, 43:623-653.
-
(2004)
Clin Pharmacokinet
, vol.43
, pp. 623-653
-
-
Staatz, C.E.1
Tett, S.E.2
-
62
-
-
33646439263
-
Tacrolimus dose requirement in relation to donor and recipient ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients
-
Wei-Lin W., Jing J., Shu-Sen Z., et al. Tacrolimus dose requirement in relation to donor and recipient ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients. Liver Transpl 2006, 12:775-780.
-
(2006)
Liver Transpl
, vol.12
, pp. 775-780
-
-
Wei-Lin, W.1
Jing, J.2
Shu-Sen, Z.3
-
63
-
-
70349243452
-
No impact of age on dose-adjusted pharmacokinetics of tacrolimus, mycophenolic acid and prednisolone 1 month after renal transplantation
-
Miura M., Satoh S., Kagaya H., et al. No impact of age on dose-adjusted pharmacokinetics of tacrolimus, mycophenolic acid and prednisolone 1 month after renal transplantation. Eur J Clin Pharmacol 2009, 65:1047-1053.
-
(2009)
Eur J Clin Pharmacol
, vol.65
, pp. 1047-1053
-
-
Miura, M.1
Satoh, S.2
Kagaya, H.3
-
64
-
-
84891867528
-
Importance of hematocrit for a tacrolimus target concentration strategy
-
Storset E., Holford N., Midtvedt K., Bremer S., Bergan S., Asberg A. Importance of hematocrit for a tacrolimus target concentration strategy. Eur J Clin Pharmacol 2014, 70:65-77.
-
(2014)
Eur J Clin Pharmacol
, vol.70
, pp. 65-77
-
-
Storset, E.1
Holford, N.2
Midtvedt, K.3
Bremer, S.4
Bergan, S.5
Asberg, A.6
-
65
-
-
84870507915
-
Lower calcineurin inhibitor doses in older compared to younger kidney transplant recipients yield similar troughs
-
Jacobson P.A., Schladt D., Oetting W.S., et al. Lower calcineurin inhibitor doses in older compared to younger kidney transplant recipients yield similar troughs. Am J Transplant 2012, 12:3326-3336.
-
(2012)
Am J Transplant
, vol.12
, pp. 3326-3336
-
-
Jacobson, P.A.1
Schladt, D.2
Oetting, W.S.3
-
66
-
-
84888013795
-
Population pharmacokinetics of cyclosporine in transplant recipients
-
Han K., Pillai V.C., Venkataramanan R. Population pharmacokinetics of cyclosporine in transplant recipients. AAPS J 2013, 15:901-912.
-
(2013)
AAPS J
, vol.15
, pp. 901-912
-
-
Han, K.1
Pillai, V.C.2
Venkataramanan, R.3
-
67
-
-
69849104464
-
A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipients
-
Falck P., Midtvedt K., Van Le T.T., et al. A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipients. Clin Pharmacokinet 2009, 48:615-623.
-
(2009)
Clin Pharmacokinet
, vol.48
, pp. 615-623
-
-
Falck, P.1
Midtvedt, K.2
Van Le, T.T.3
-
68
-
-
23944478373
-
Population pharmacokinetics of cyclosporine in clinical renal transplant patients
-
Wu K.H., Cui Y.M., Guo J.F., et al. Population pharmacokinetics of cyclosporine in clinical renal transplant patients. Drug Metab Dispos 2005, 33:1268-1275.
-
(2005)
Drug Metab Dispos
, vol.33
, pp. 1268-1275
-
-
Wu, K.H.1
Cui, Y.M.2
Guo, J.F.3
-
69
-
-
0032837161
-
Cyclosporin pharmacokinetics in the elderly
-
Kovarik J.M., Koelle E.U. Cyclosporin pharmacokinetics in the elderly. Drugs Aging 1999, 15:197-205.
-
(1999)
Drugs Aging
, vol.15
, pp. 197-205
-
-
Kovarik, J.M.1
Koelle, E.U.2
-
70
-
-
58149354277
-
Reduced elimination of cyclosporine A in elderly (>65 years) kidney transplant recipients
-
Falck P., Asberg A., Byberg K.T., et al. Reduced elimination of cyclosporine A in elderly (>65 years) kidney transplant recipients. Transplantation 2008, 86:1379-1383.
-
(2008)
Transplantation
, vol.86
, pp. 1379-1383
-
-
Falck, P.1
Asberg, A.2
Byberg, K.T.3
-
71
-
-
84903439322
-
Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update
-
Staatz C.E., Tett S.E. Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update. Arch Toxicol 2014, 88:1351-1389.
-
(2014)
Arch Toxicol
, vol.88
, pp. 1351-1389
-
-
Staatz, C.E.1
Tett, S.E.2
-
72
-
-
0038246498
-
Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies
-
Shaw L.M., Korecka M., Venkataramanan R., Goldberg L., Bloom R., Brayman K.L. Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies. Am J Transplant 2003, 3:534-542.
-
(2003)
Am J Transplant
, vol.3
, pp. 534-542
-
-
Shaw, L.M.1
Korecka, M.2
Venkataramanan, R.3
Goldberg, L.4
Bloom, R.5
Brayman, K.L.6
-
73
-
-
0033160692
-
The effect of renal insufficiency on mycophenolic acid protein binding
-
Kaplan B., Meier-Kriesche H.U., Friedman G., et al. The effect of renal insufficiency on mycophenolic acid protein binding. J Clin Pharmacol 1999, 39:715-720.
-
(1999)
J Clin Pharmacol
, vol.39
, pp. 715-720
-
-
Kaplan, B.1
Meier-Kriesche, H.U.2
Friedman, G.3
-
74
-
-
33645450634
-
Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients
-
Van Hest R.M., Mathot R.A., Pescovitz M.D., Gordon R., Mamelok R.D., Van Gelder T. Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients. J Am Soc Nephrol 2006, 17:871-880.
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 871-880
-
-
Van Hest, R.M.1
Mathot, R.A.2
Pescovitz, M.D.3
Gordon, R.4
Mamelok, R.D.5
Van Gelder, T.6
-
75
-
-
34250204444
-
Population pharmacokinetics of mycophenolic acid in senile Chinese kidney transplant recipients
-
Wang C.X., Meng F.H., Chen L.Z., et al. Population pharmacokinetics of mycophenolic acid in senile Chinese kidney transplant recipients. Transplant Proc 2007, 39:1392-1395.
-
(2007)
Transplant Proc
, vol.39
, pp. 1392-1395
-
-
Wang, C.X.1
Meng, F.H.2
Chen, L.Z.3
-
76
-
-
0034746371
-
Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine
-
Kovarik J.M., Kahan B.D., Kaplan B., et al. Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine. Clin Pharmacol Ther 2001, 69:48-56.
-
(2001)
Clin Pharmacol Ther
, vol.69
, pp. 48-56
-
-
Kovarik, J.M.1
Kahan, B.D.2
Kaplan, B.3
-
77
-
-
0034834765
-
Population pharmacokinetics of everolimus in de novo renal transplant patients: impact of ethnicity and comedications
-
Kovarik J.M., Hsu C.H., Mcmahon L., Berthier S., Rordorf C. Population pharmacokinetics of everolimus in de novo renal transplant patients: impact of ethnicity and comedications. Clin Pharmacol Ther 2001, 70:247-254.
-
(2001)
Clin Pharmacol Ther
, vol.70
, pp. 247-254
-
-
Kovarik, J.M.1
Hsu, C.H.2
Mcmahon, L.3
Berthier, S.4
Rordorf, C.5
-
78
-
-
84903786099
-
Focus on mTOR inhibitors and tacrolimus in renal transplantation: pharmacokinetics, exposure-response relationships, and clinical outcomes
-
Shihab F., Christians U., Smith L., Wellen J.R., Kaplan B. Focus on mTOR inhibitors and tacrolimus in renal transplantation: pharmacokinetics, exposure-response relationships, and clinical outcomes. Transpl Immunol 2014, 31:22-32.
-
(2014)
Transpl Immunol
, vol.31
, pp. 22-32
-
-
Shihab, F.1
Christians, U.2
Smith, L.3
Wellen, J.R.4
Kaplan, B.5
-
79
-
-
0035077039
-
Therapeutic drug monitoring of sirolimus for optimal renal transplant outcomes
-
Kahan B.D., Napoli K.L., Podbielski J., Hussein I., Katz S.H., Van Buren C.T. Therapeutic drug monitoring of sirolimus for optimal renal transplant outcomes. Transplant Proc 2001, 33:1278.
-
(2001)
Transplant Proc
, vol.33
, pp. 1278
-
-
Kahan, B.D.1
Napoli, K.L.2
Podbielski, J.3
Hussein, I.4
Katz, S.H.5
Van Buren, C.T.6
-
80
-
-
33748750319
-
A Bayesian approach for population pharmacokinetic modelling of sirolimus
-
Dansirikul C., Morris R.G., Tett S.E., Duffull S.B. A Bayesian approach for population pharmacokinetic modelling of sirolimus. Br J Clin Pharmacol 2006, 62:420-434.
-
(2006)
Br J Clin Pharmacol
, vol.62
, pp. 420-434
-
-
Dansirikul, C.1
Morris, R.G.2
Tett, S.E.3
Duffull, S.B.4
-
81
-
-
84864127871
-
Time-varying belatacept exposure and its relationship to efficacy/safety responses in kidney-transplant recipients
-
Zhou Z., Shen J., Hong Y., Kaul S., Pfister M., Roy A. Time-varying belatacept exposure and its relationship to efficacy/safety responses in kidney-transplant recipients. Clin Pharmacol Ther 2012, 92:251-257.
-
(2012)
Clin Pharmacol Ther
, vol.92
, pp. 251-257
-
-
Zhou, Z.1
Shen, J.2
Hong, Y.3
Kaul, S.4
Pfister, M.5
Roy, A.6
-
82
-
-
76949101581
-
A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)
-
Vincenti F., Charpentier B., Vanrenterghem Y., et al. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant 2010, 10:535-546.
-
(2010)
Am J Transplant
, vol.10
, pp. 535-546
-
-
Vincenti, F.1
Charpentier, B.2
Vanrenterghem, Y.3
-
83
-
-
76949090842
-
A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study)
-
Durrbach A., Pestana J.M., Pearson T., et al. A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study). Am J Transplant 2010, 10:547-557.
-
(2010)
Am J Transplant
, vol.10
, pp. 547-557
-
-
Durrbach, A.1
Pestana, J.M.2
Pearson, T.3
-
84
-
-
84876289552
-
FDA perspective: enrolment of elderly transplant recipients in clinical trials
-
Meyer J.M., Archdeacon P., Albrecht R. FDA perspective: enrolment of elderly transplant recipients in clinical trials. Transplantation 2013, 95:916-918.
-
(2013)
Transplantation
, vol.95
, pp. 916-918
-
-
Meyer, J.M.1
Archdeacon, P.2
Albrecht, R.3
-
85
-
-
75649088107
-
Pharmacodynamic monitoring of calcineurin inhibition therapy: principles, performance, and perspectives
-
Van Rossum H.H., De Fijter J.W., Van Pelt J. Pharmacodynamic monitoring of calcineurin inhibition therapy: principles, performance, and perspectives. Ther Drug Monit 2010, 32:3-10.
-
(2010)
Ther Drug Monit
, vol.32
, pp. 3-10
-
-
Van Rossum, H.H.1
De Fijter, J.W.2
Van Pelt, J.3
-
86
-
-
34548687467
-
Pharmacokinetics and pharmacodynamics in renal transplant recipients under treatment with cyclosporine and Myfortic
-
Brunet M., Crespo M., Millan O., et al. Pharmacokinetics and pharmacodynamics in renal transplant recipients under treatment with cyclosporine and Myfortic. Transplant Proc 2007, 39:2160-2162.
-
(2007)
Transplant Proc
, vol.39
, pp. 2160-2162
-
-
Brunet, M.1
Crespo, M.2
Millan, O.3
-
87
-
-
84862759750
-
Calcineurin inhibitors and NFAT-regulated gene expression
-
Sommerer C., Meuer S., Zeier M., Giese T. Calcineurin inhibitors and NFAT-regulated gene expression. Clin Chim Acta 2012, 413:1379-1386.
-
(2012)
Clin Chim Acta
, vol.413
, pp. 1379-1386
-
-
Sommerer, C.1
Meuer, S.2
Zeier, M.3
Giese, T.4
-
88
-
-
80051802715
-
Pharmacodynamic disparities in tacrolimus-treated patients developing cytomegalus virus viremia
-
Sommerer C., Zeier M., Czock D., Schnitzler P., Meuer S., Giese T. Pharmacodynamic disparities in tacrolimus-treated patients developing cytomegalus virus viremia. Ther Drug Monit 2011, 33:373-379.
-
(2011)
Ther Drug Monit
, vol.33
, pp. 373-379
-
-
Sommerer, C.1
Zeier, M.2
Czock, D.3
Schnitzler, P.4
Meuer, S.5
Giese, T.6
-
89
-
-
77953359811
-
Individualized monitoring of nuclear factor of activated T cells-regulated gene expression in FK506-treated kidney transplant recipients
-
Sommerer C., Zeier M., Meuer S., Giese T. Individualized monitoring of nuclear factor of activated T cells-regulated gene expression in FK506-treated kidney transplant recipients. Transplantation 2010, 89:1417-1423.
-
(2010)
Transplantation
, vol.89
, pp. 1417-1423
-
-
Sommerer, C.1
Zeier, M.2
Meuer, S.3
Giese, T.4
-
90
-
-
84893417691
-
Pharmacodynamic monitoring of nuclear factor of activated T cell-regulated gene expression in liver allograft recipients on immunosuppressive therapy with calcineurin inhibitors in the course of time and correlation with acute rejection episodes-a prospective stud
-
Steinebrunner N., Sandig C., Sommerer C., et al. Pharmacodynamic monitoring of nuclear factor of activated T cell-regulated gene expression in liver allograft recipients on immunosuppressive therapy with calcineurin inhibitors in the course of time and correlation with acute rejection episodes-a prospective stud. Ann Transplant 2014, 19:32-40.
-
(2014)
Ann Transplant
, vol.19
, pp. 32-40
-
-
Steinebrunner, N.1
Sandig, C.2
Sommerer, C.3
-
91
-
-
84856115743
-
Pharmacodynamic monitoring of cyclosporin A reveals risk of opportunistic infections and malignancies in renal transplant recipients 65 years and older
-
Sommerer C., Schnitzler P., Meuer S., Zeier M., Giese T. Pharmacodynamic monitoring of cyclosporin A reveals risk of opportunistic infections and malignancies in renal transplant recipients 65 years and older. Ther Drug Monit 2011, 33:694-698.
-
(2011)
Ther Drug Monit
, vol.33
, pp. 694-698
-
-
Sommerer, C.1
Schnitzler, P.2
Meuer, S.3
Zeier, M.4
Giese, T.5
-
92
-
-
34248158954
-
Monitoring of inosine monophosphate dehydrogenase activity as a biomarker for mycophenolic acid effect: potential clinical implications
-
Weimert N.A., Derotte M., Alloway R.R., Woodle E.S., Vinks A.A. Monitoring of inosine monophosphate dehydrogenase activity as a biomarker for mycophenolic acid effect: potential clinical implications. Ther Drug Monit 2007, 29:141-149.
-
(2007)
Ther Drug Monit
, vol.29
, pp. 141-149
-
-
Weimert, N.A.1
Derotte, M.2
Alloway, R.R.3
Woodle, E.S.4
Vinks, A.A.5
-
93
-
-
84892902706
-
Tacrolimus exposure and mycophenolate pharmacokinetics and pharmacodynamics early after liver transplantation
-
Saeves I., Line P.D., Bremer S., et al. Tacrolimus exposure and mycophenolate pharmacokinetics and pharmacodynamics early after liver transplantation. Ther Drug Monit 2014, 36:46-53.
-
(2014)
Ther Drug Monit
, vol.36
, pp. 46-53
-
-
Saeves, I.1
Line, P.D.2
Bremer, S.3
-
94
-
-
13144281731
-
Mycophenolate mofetil: how to further improve using an already successful drug?
-
Van Gelder T. Mycophenolate mofetil: how to further improve using an already successful drug?. Am J Transplant 2005, 5:199-200.
-
(2005)
Am J Transplant
, vol.5
, pp. 199-200
-
-
Van Gelder, T.1
-
95
-
-
33846230492
-
Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients
-
Staatz C.E., Tett S.E. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. Clin Pharmacokinet 2007, 46:13-58.
-
(2007)
Clin Pharmacokinet
, vol.46
, pp. 13-58
-
-
Staatz, C.E.1
Tett, S.E.2
-
96
-
-
70349668493
-
Inosine monophosphate dehydrogenase messenger RNA expression is correlated to clinical outcomes in mycophenolate mofetil-treated kidney transplant patients, whereas inosine monophosphate dehydrogenase activity is not
-
Sombogaard F., Peeters A.M., Baan C.C., et al. Inosine monophosphate dehydrogenase messenger RNA expression is correlated to clinical outcomes in mycophenolate mofetil-treated kidney transplant patients, whereas inosine monophosphate dehydrogenase activity is not. Ther Drug Monit 2009, 31:549-556.
-
(2009)
Ther Drug Monit
, vol.31
, pp. 549-556
-
-
Sombogaard, F.1
Peeters, A.M.2
Baan, C.C.3
-
97
-
-
32844467779
-
Biochemical monitoring of mTOR inhibitor-based immunosuppression following kidney transplantation: a novel approach for tailored immunosuppressive therapy
-
Hartmann B., Schmid G., Graeb C., et al. Biochemical monitoring of mTOR inhibitor-based immunosuppression following kidney transplantation: a novel approach for tailored immunosuppressive therapy. Kidney Int 2005, 68:2593-2598.
-
(2005)
Kidney Int
, vol.68
, pp. 2593-2598
-
-
Hartmann, B.1
Schmid, G.2
Graeb, C.3
-
98
-
-
34447622296
-
Monitoring biological action of rapamycin in renal transplantation
-
Leogrande D., Teutonico A., Ranieri E., et al. Monitoring biological action of rapamycin in renal transplantation. Am J Kidney Dis 2007, 50:314-325.
-
(2007)
Am J Kidney Dis
, vol.50
, pp. 314-325
-
-
Leogrande, D.1
Teutonico, A.2
Ranieri, E.3
-
99
-
-
84875185944
-
Development of a sensitive phospho-p70 S6 kinase ELISA to quantify mTOR proliferation signal inhibition
-
Hartmann B., He X., Keller F., Fischereder M., Guba M., Schmid H. Development of a sensitive phospho-p70 S6 kinase ELISA to quantify mTOR proliferation signal inhibition. Ther Drug Monit 2013, 35:233-239.
-
(2013)
Ther Drug Monit
, vol.35
, pp. 233-239
-
-
Hartmann, B.1
He, X.2
Keller, F.3
Fischereder, M.4
Guba, M.5
Schmid, H.6
-
100
-
-
84920271436
-
Pharmacodynamic monitoring of mammalian target of rapamycin inhibition by phosphoflow cytometric determination of p70S6 kinase activity
-
Hoerning A., Wilde B., Wang J., et al. Pharmacodynamic monitoring of mammalian target of rapamycin inhibition by phosphoflow cytometric determination of p70S6 kinase activity. Transplantation 2015, 99:210-219.
-
(2015)
Transplantation
, vol.99
, pp. 210-219
-
-
Hoerning, A.1
Wilde, B.2
Wang, J.3
-
101
-
-
75749102266
-
Kidney disease: improving global outcomes transplant work G. KDIGO clinical practice guideline for the care of kidney transplant recipients
-
Kidney disease: improving global outcomes transplant work G. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009, 9:S1-S155.
-
(2009)
Am J Transplant
, vol.9
, pp. S1-S155
-
-
-
102
-
-
79957843431
-
Induction immunosuppressive therapy in the elderly kidney transplant recipient in the United States
-
Gill J., Sampaio M., Gill J.S., et al. Induction immunosuppressive therapy in the elderly kidney transplant recipient in the United States. Clin J Am Soc Nephrol 2011, 6:1168-1178.
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, pp. 1168-1178
-
-
Gill, J.1
Sampaio, M.2
Gill, J.S.3
-
103
-
-
79953193081
-
Low-dose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy
-
Laftavi M.R., Patel S., Soliman M.R., et al. Low-dose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy. Transplant Proc 2011, 43:466-468.
-
(2011)
Transplant Proc
, vol.43
, pp. 466-468
-
-
Laftavi, M.R.1
Patel, S.2
Soliman, M.R.3
-
104
-
-
84880070494
-
Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients
-
Khanmoradi K., Knorr J.P., Feyssa E.L., et al. Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients. Exp Clin Transplant 2013, 11:222-228.
-
(2013)
Exp Clin Transplant
, vol.11
, pp. 222-228
-
-
Khanmoradi, K.1
Knorr, J.P.2
Feyssa, E.L.3
|